A detailed history of Massachusetts Financial Services CO transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 178,932 shares of MDXG stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
178,932
Previous 183,263 2.36%
Holding current value
$1.63 Million
Previous $1.27 Million 16.77%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.65 - $7.76 $24,470 - $33,608
-4,331 Reduced 2.36%
178,932 $1.06 Million
Q2 2024

Aug 09, 2024

BUY
$6.16 - $8.08 $37,840 - $49,635
6,143 Added 3.47%
183,263 $1.27 Million
Q1 2024

May 14, 2024

SELL
$7.61 - $8.63 $3,036 - $3,443
-399 Reduced 0.22%
177,120 $1.36 Million
Q4 2023

Feb 08, 2024

SELL
$5.7 - $9.14 $31,965 - $51,257
-5,608 Reduced 3.06%
177,519 $1.56 Million
Q3 2023

Nov 08, 2023

SELL
$6.35 - $8.16 $44,526 - $57,217
-7,012 Reduced 3.69%
183,127 $1.33 Million
Q2 2023

Aug 09, 2023

BUY
$3.14 - $6.61 $597,036 - $1.26 Million
190,139 New
190,139 $1.26 Million
Q3 2018

Oct 25, 2018

SELL
$3.22 - $6.33 $1.79 Million - $3.52 Million
-556,510 Closed
0 $0
Q2 2018

Jul 30, 2018

SELL
$5.39 - $8.96 $461,976 - $767,961
-85,710 Reduced 13.35%
556,510 $3.56 Million
Q1 2018

May 04, 2018

SELL
$6.69 - $17.96 $426,447 - $1.14 Million
-63,744 Reduced 9.03%
642,220 $4.48 Million
Q4 2017

Feb 14, 2018

BUY
$10.87 - $13.9 $227,846 - $291,357
20,961 Added 3.06%
705,964 $8.9 Million
Q3 2017

Nov 14, 2017

SELL
$11.86 - $17.34 $3.15 Million - $4.61 Million
-265,608 Reduced 27.94%
685,003 $8.14 Million
Q2 2017

Aug 14, 2017

BUY
N/A
950,611
950,611 $14.2 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.03B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.